Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D 100 winner of the day: Spectral Phenotyping with MirroRx

By Heather Hall | June 30, 2023

Lawrence Berkeley National Laboratory’s MirroRx is a biomarker technology that accurately predicts disease status. The disease phenotype is analyzed by measuring how the patient’s endogenous molecules vibrate upon exposure to infrared light. The difference between the vibrational profiles of disease and control samples is so visible that the spectral process is like “cellular fingerprinting.” Aggressive cancers such as ovarian and gliomas have low survival rates, but the disease cells have little to distinguish them from non-disease cells. Neither the presence of disease nor its prognosis is predictable. New biomarkers are needed if we are to improve the outcome of clinical trials or to develop more effective therapies. Towards that goal, early results with MirroRx on a handful of samples from presymptomatic patients – who later developed Alzheimer’s – indicate that the technology can spot Alzheimer’s before symptoms develop. If this holds true in future validation trials, spectral phenotyping by MirroRx may, at long last, provide a window of time for patients to try experimental medicines that could delay or even stop disease progression.

Related Articles Read More >

2024’s R&D 100 Researcher of the Year on the drive that inspired him to create digital twins of 141 million buildings
R&D 100 Awards
The 2025 R&D 100 Awards are now open for nominations
R&D 100 Awards
Call for Nominations: The 2025 R&D 100 Awards
R&D 100 winner of the day: Berelex Green eco-friendly, antiviral, antifungal, and antibacterial paint
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE